Genetic aspects of von Hippel-Lindau (VHL) disease were studied in familial and isolated cases. Complex segregation analysis with pointers was performed in 38 kindreds with two or more affected members. Dominant inheritance with almost complete penetrance in the highest age classes (0*96 at 51 to 60 and 0.99 at 61 to 70 years) was confirmed and there was no evidence of heterogeneity between families ascertained through complete and incomplete selection. The point prevalence of heterozygotes in East Anglia was 1-89/100 000 (1/53 000) persons with an estimated birth incidence of 2-73/100 000 (1/36 000) live births. Reproductive fitness was 0-83. Direct and indirect estimates of the mutation rate were 4-4 (95% CI 0-9 to 7-9)x ie/gene/generation and 2*32x 10t6/gene/generation respectively. There was no significant association between parental age or birth order and new mutations for VHL disease.
association between retinal angiomas and cerebellar haemangioblastoma and described the development of hypernephroma in 1927. More than 700 patients with VHL disease have been reported2 3 and the clinical features have been well defined. Nevertheless, some of the genetic aspects of VHL disease have received little attention. Dominant inheritance was suggested by M0ller,8 and several large families in which VHL disease segregated as a dominant trait through five2 9 and six10 generations have since been described.
However, Shokeir" proposed autosomal recessive inheritance in one family. We report complex segregation analysis and estimates of the prevalence, fitness, mutation rate, and parental age effect in VHL disease.
Patients and methods

PATIENT DETAILS
Patients with VHL disease from 66 kindreds containing 236 affected subjects and 194 unaffected relatives at 50% prior risk were analysed. Twelve kindreds contained only one affected person. Most patients were included in previous clinical studies of VHL disease. 3 12 Genetic linkage studies in 14 families have been described elsewhere. 13 Patients were ascertained by contacting specialists in genetics, nephrology, neurology, neurosurgery, ophthalmology, and urology from Great Britain and Ireland. Details of families with multiple affected members and ofisolated cases were requested. VHL disease was diagnosed by conventional criteria1: for isolated cases two or more haemangioblastomas, or a single haemangioblastoma in association with a visceral manifestation are required. When there is a family history of retinal or CNS haemangioblastoma, only one haemangioblastoma or visceral complication is required to make the diagnosis of VHL disease. Details of the clinical status and age at diagnosis were confirmed from patient interviews, hospital notes, and necropsy records.
SEGREGATION ANALYSIS OF FAMILIAL CASES
Thirty-eight pedigrees containing 194 patients for whom detailed age at onset information was available were submitted for complex segregation analysis with multiple pointers. Each subject was assigned to one of eight age related liability classes. The risk attributed to the jth liability class was Rj=(Ij-Mh,)/(l-Mj_1) where Ii is the cumulative incidence to the midpoint of j and Mb, is the cumulative specific mortality to the end of the preceding class. The Ii values were estimated from the age at onset data in the material and Mi values from the survival curve using the actuarial method.3 It was assumed that the prevalence of VHL disease in the highest age group was 1/100 000. A total of 610 subjects from 114 nuclear families were submitted to segregation analysis using the computer program POINTER. 14 Prevalence, birth frequency, mutation rates, and parental age and birth order effects were studied by standard methods. 15 The prevalence of heterozygotes was determined in East Anglia (population 2 034 400) as ascertainment was most likely to be complete in this region. There were 24 affected patients (six of whom were isolated cases) and 32 relatives at 50% prior risk from 18 kindreds in East Anglia. Of these, 16 for the maximum likelihood estimate. These values of 2q bracket the incidence estimated below. Because of specific mortality, the segregation analysis will underestimate gene frequency.
There was no significant heterogeneity between families ascertained through complete and incomplete selection (y3=5 54).
PREVALENCE AND INCIDENCE OF VHL DISEASE
On the study day (1 July 1990) there were 24 affected patients (16 index cases) and 32 relatives at 50% prior risk alive in East Anglia. Analysis of the at risk relatives using age at onset data (see above) showed that there were likely to be 9-4 heterozygotes among them. Estimation of mutation rate by the indirect method The reproductive fitness was combined with the estimated birth frequency for VHL disease (see above) and a mutation rate of 2-32x 10-6 per gene calculated by the indirect method. This is within the The prevalence of heterozygotes for VHL disease in East Anglia (1/54 000) is higher than that in some previous reports. VHL disease is often not diagnosed unless at risk relatives and patients with apparently isolated retinal angioma or cerebellar haemangioblastoma are carefully screened for other manifestations. The proportion of patients with VHL disease among all patients with cerebellar haemangioblastoma has been variously estimated at 0%,20 3.6% 21 9.2% 22 14.5%)23 23%,24 and 40%.13 Although Piotrowski and Rohrborn25 found a prevalence of 1 in 230 000 in northern Germany, Neumann26 (personal communication) found the prevalence of affected patients in south western Germany to be 1 per 40 000 persons, which is closer to that found by us in East Anglia. We believe that these higher prevalence rates result from more complete ascertainment. Although variations in the prevalence of a rare disorder between areas might result from the presence of a single huge kindred in one region, no single family contributed more than 17% of the total number of heterozygotes in East Anglia. Furthermore the frequency of isolated patients with VHL disease in East Anglia was considerably greater than that reported elsewhere. 25 VHL disease may cause death or severe handicap in early adulthood and it might be anticipated that reproductive fitness would be reduced in this disorder. We found a reproductive fitness of 0-83 but are not aware of any other estimates. The difficulty in recognising new mutations for VHL disease in the absence of other affected relatives has been discussed. The mutation rate for VHL disease was not significantly different when calculated directly or estimated by the indirect method. The direct estimate (4 33 It has been shown recently that there is a predisposition for new mutations to arise in the paternal germline in retinoblastoma and von Recklinghausen neurofibromatosis,34 two dominantly inherited conditions for which no paternal age effect is apparent. Studies to determine whether a similar situation occurs in VHL disease are in progress.
Detailed information on the data used for the segregation analysis can be provided to interested persons by the first author.
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